BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17827439)

  • 1. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
    Sato T; Nakajima T; Yamano Y
    Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries?
    Warden SJ
    Sports Med; 2005; 35(4):271-83. PubMed ID: 15831058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
    Jachak SM
    Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment.
    Larsson K; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():161-5. PubMed ID: 26100239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
    Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
    J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitors. What is their place?
    McGettigan P
    Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is mPGES-1 a promising target for pain therapy?
    Scholich K; Geisslinger G
    Trends Pharmacol Sci; 2006 Aug; 27(8):399-401. PubMed ID: 16815559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase.
    Greco A; Ajmone-Cat MA; Nicolini A; Sciulli MG; Minghetti L
    J Neurosci Res; 2003 Mar; 71(6):844-52. PubMed ID: 12605411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
    He W; Liu CF; Huang CQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic strategies beyond the inhibition of cyclooxygenases.
    Zeilhofer HU; Brune K
    Trends Pharmacol Sci; 2006 Sep; 27(9):467-74. PubMed ID: 16876882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new mPGES-1 inhibitor in rat models of inflammation.
    Leclerc P; Pawelzik SC; Idborg H; Spahiu L; Larsson C; Stenberg P; Korotkova M; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2013; 102-103():1-12. PubMed ID: 23528231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.